Implantation of Esteem
DeviceSubjects meeting indications are implanted with the Esteem Totally Implantable Hearing System
NCT Number: NCT02689349
The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
North Alabama ENT Associates, Madison, Alabama, United States
Purpose:
To evaluate the long-term safety and efficacy of the Esteem Totally Implantable Hearing System (hereafter called Esteem) in subjects suffering from moderate to severe hearing loss.
Questions:
The following questions are to be answered:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects meeting indications are implanted with the Esteem Totally Implantable Hearing System
Time frame: Change in SRT from Baseline Aided to 10-month post-activation with Esteem
Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition. The SRT is related to hearing sensitivity; lower numbers indicate better outcomes. Here, the difference in dB is reported; positive scores indicate improvement (lower SRT) with the Esteem relative to the pre-implant hearing aid. There are no specific minimum or maximum scores for this measure.
Time frame: Change in WRS from Baseline Aided to 10-month post-activation with Esteem
Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition. For WRS, a higher score indicates a better outcome. Here, the difference in % correct is reported; positive scores indicate better performance with the Esteem relative to the pre-implant hearing aid. Scores on this test range from 0 to 100%.
Time frame: Incidence at 10-month post-activation
The analysis of the incidence of Serious Adverse Device Effects (SADEs) and device failures and replacements
Time frame: Incidence at one month post-op
The analysis of the incidence of facial pareses/paralysis at one month follow-up
Time frame: Change in BCT from Baseline to 10-month post-activation
Comparison of bone conduction (BC) threshold at 500 Hz post activation compared to the pre-implant BC threshold. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change from Baseline Aided to 10-month post-activation with Esteem
Quality of Life measured with the APHAB comparison between the pre-implant aided condition and 10-month post-activation. In general, a lower score indicates better performance. The range of scores for each subscale (including the Global score, reported here) is 1 to 99. Here, mean difference in benefit score with the Esteem implant vs. pre-implant aided condition is reported. A positive difference score indicates more benefit with the Esteem.
Time frame: 10-month post-activation with Esteem
To gather subject feedback and comments on the use of the Esteem System through subject ratings on questionnaire items specifically focusing on factors such as the clarity of sound, the user's ability to understand speech in background noise, naturalness of sound, benefits of the system, etc. -- relative to the pre-implant aided condition. Subjects rated each item as "Is much worse", "Somewhat worse", "Is about the same", "Is somewhat better", or "Is much better" with the Esteem. Reported here are the cumulative number of respondents indicating "Same", "Somewhat better", or "Much better" for the given question.
Envoy Medical Corporation
Industry
Esteem Totally Implantable Hearing System New Subject Enrollment Post Approval Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00023036
Cytomegalovirus Infection, Cytomegalovirus Infections
Bethesda, Maryland, United States
View Trial DetailsNCT02038972
Ear Diseases, Hearing Disorders
Orlando, Florida, United States
View Trial DetailsNCT05402969
Ear Diseases, Fibrosis
Montpellier, France
View Trial DetailsNCT00023049
Deafness, Ear Diseases
Bethesda, Maryland, United States
View Trial Details